Search for: "Jiao Yuxin"
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
10 Feb 2017, 12:40 am
Hui Zhang, Jiao Yuxin and Dani MinZY PartnersA positive view is spreading on post-filing experimental data in China since the recent official post of the proposed revisions to the Guidelines for Patent Examination (the “Guidelines”) by the State IP Office (the “SIPO”) of China. [read post]
4 May 2017, 1:00 am
Jiao Yuxin, Hui Zhang and Yi WeiPharmaceutical polymorph patents are regarded as effective means and important secondary pharmaceutical patents to extend the life cycle of pharmaceutical patent protection. [read post]
